$FLD
FTAC Emerald Acquisition Corp Stock $fld

$fld Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000121390024025648 Filed on March 26, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.479M	$3.730M	$458.1K
YoY Change	222.98%	109.94%	356.65%
Operating Profit		-$3.730M
YoY Change		109.95%
Interest Expense	$2.180M	$11.21M	$2.122M
YoY Change	2.73%	209.68%	400232.08%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$708.4K
YoY Change
Pretax Income	$700.2K	$6.769M	$1.664M
YoY Change	-57.91%	267.43%	-1767.35%
Income Tax	$458.6K	$2.325M	$462.4K
% Of Pretax Income	65.49%	34.35%	27.79%
Net Earnings	$241.6K	$4.444M	$1.201M
YoY Change	-79.89%	298.26%	-1303.93%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.01	$0.14	$0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.84K	$29.84K	$72.75K
YoY Change	-58.98%	-58.98%	-94.08%
Cash & Equivalents	$29.84K		$72.75K
Short-Term Investments
Other Short-Term Assets	$276.2K	$276.2K	$185.2K
YoY Change	49.14%	49.14%	-54.98%
Inventory
Prepaid Expenses	$192.7K		$185.2K
Receivables
Other Receivables
Total Short-Term Assets	$306.1K	$306.1K	$258.0K
YoY Change	18.64%	18.64%	-84.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$165.7M	$165.7M	$254.3M
YoY Change	-34.85%	-34.85%	14.42%
Other Assets
YoY Change
Total Long-Term Assets	$165.7M	$165.7M	$255.4M
YoY Change	-35.14%	-35.14%	14.26%
TOTAL ASSETS
Total Short-Term Assets	$306.1K	$306.1K	$258.0K
Total Long-Term Assets	$165.7M	$165.7M	$255.4M
Total Assets	$166.0M	$166.0M	$255.7M
YoY Change	-35.09%	-35.09%	13.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$114.7K	$114.7K	$111.1K
YoY Change	3.24%	3.24%
Accrued Expenses	$967.9K	$967.9K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$2.311M	$2.311M	$21.54K
YoY Change	10630.97%	10630.97%	30.94%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.394M	$3.394M	$492.0K
YoY Change	589.83%	589.83%	425.75%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.155M	$1.155M	$9.859M
YoY Change	-88.29%	-88.29%	11.34%
Total Long-Term Liabilities	$1.155M	$1.155M	$9.859M
YoY Change	-88.29%	-88.29%	11.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.394M	$3.394M	$492.0K
Total Long-Term Liabilities	$1.155M	$1.155M	$9.859M
Total Liabilities	$4.549M	$4.549M	$10.35M
YoY Change	-56.05%	-56.05%	15.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.30M		-$8.502M
YoY Change	32.88%		42.18%
Common Stock			$98.00
YoY Change			10.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$161.4M	$161.4M	-$8.501M
YoY Change
Total Liabilities & Shareholders Equity	$166.0M	$166.0M	$255.7M
YoY Change	-35.09%	-35.09%	13.54%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	$241.6K	$4.444M	$1.201M
YoY Change	-79.89%	298.26%	-1303.93%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.043M	-$5.082M	-$629.1K
YoY Change	65.85%	198.38%	6.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$522.5K	$99.81M	$310.9K
YoY Change	68.07%	-451.03%	-100.14%
Cash From Investing Activities	$522.5K	$99.81M	$310.9K
YoY Change	68.07%	-451.03%	-100.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$96.79M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	525.0K	-94.77M	0.000
YoY Change		-427.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-1.043M	-5.082M	-629.1K
Cash From Investing Activities	522.5K	99.81M	310.9K
Cash From Financing Activities	525.0K	-94.77M	0.000
Net Change In Cash	4.220K	-42.91K	-318.2K
YoY Change	-101.33%	-96.29%	-126.45%
FREE CASH FLOW
Cash From Operating Activities	-$1.043M	-$5.082M	-$629.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41168
CY2023	dei	Entity Registrant Name EntityRegistrantName	FTAC EMERALD ACQUISITION CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2170416
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2929 Arch Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1703
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Philadelphia
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19104
CY2023	dei	City Area Code CityAreaCode	(215)
CY2023	dei	Local Phone Number LocalPhoneNumber	701-9555
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	257400000	usd
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2023	dei	Auditor Location AuditorLocation	New York
CY2023	dei	Auditor Firm AuditorFirmId	100
CY2023Q4	us-gaap	Cash Cash	29844	usd
CY2022Q4	us-gaap	Cash Cash	72753	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	192712	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	185213	usd
CY2023Q4	emld	Prepaid Income Taxes Current PrepaidIncomeTaxesCurrent	83503	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	306059	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	257966	usd
CY2022Q4	emld	Reimbursement Receivable Non Current ReimbursementReceivableNonCurrent	1155000	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	165653149	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	254251750	usd
CY2023Q4	us-gaap	Assets Assets	165959208	usd
CY2022Q4	us-gaap	Assets Assets	255664716	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	114659	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	111063	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	967916	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	359410	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3394026	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	492008	usd
CY2022Q4	emld	Deferred Underwriters Discount DeferredUnderwritersDiscount	8704270	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1155000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1155000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4549026	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10351278	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	165721882	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	253814255	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6984216	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11296875	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8501776	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4311700	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8500817	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	165959208	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	255664716	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3730488	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1776887	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3730488	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1776887	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	11207609	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3619061	usd
CY2023	emld	Nonredemption Agreement Expense NonredemptionAgreementExpense	708400	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6768721	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1842174	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2325087	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	726410	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4443634	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1115764	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-5978418	usd
CY2022	emld	Sale Of Private Placement Units SaleOfPrivatePlacementUnits	860810	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	454360	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	4953333	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1115764	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8500817	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	967916	usd
CY2023	emld	Adjustments To Additional Paid In Capital Contribution For Nonredemption Agreements AdjustmentsToAdditionalPaidInCapitalContributionForNonredemptionAgreements	708400	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	8699271	usd
CY2023	emld	Adjustments To Additional Paid In Capital In Waiver Of Deferred Underwriters Fee AdjustmentsToAdditionalPaidInCapitalInWaiverOfDeferredUnderwritersFee	8704270	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4443634	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4311700	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4443634	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1115764	usd
CY2023	emld	Nonredemption Agreement Expense NonredemptionAgreementExpense	708400	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	11207609	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3619061	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7499	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-401507	usd
CY2023	emld	Increase Decrease In Prepaid Income Taxes IncreaseDecreaseInPrepaidIncomeTaxes	83503	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1155000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	290047	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	33932	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-21535	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	5084	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-359410	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	359410	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5082475	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1703364	usd
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	28980354	usd
CY2023	emld	Proceeds From Cash Withdrawn From Trust Account For Tax Purposes ProceedsFromCashWithdrawnFromTrustAccountForTaxPurposes	3014566	usd
CY2022	emld	Proceeds From Cash Withdrawn From Trust Account For Tax Purposes ProceedsFromCashWithdrawnFromTrustAccountForTaxPurposes	548195	usd
CY2023	emld	Proceedsfrom Cash Withdrawn From Trust Account In Connection With Redemption ProceedsfromCashWithdrawnFromTrustAccountInConnectionWithRedemption	96791644	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	99806210	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28432159	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	28980362	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2025000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	96791644	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-94766644	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28980362	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-42909	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1155161	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72753	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1227914	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29844	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72753	usd
CY2023	emld	Excise Tax On Stock Redemption ExciseTaxOnStockRedemption	967916	usd
CY2023	emld	Deferred Underwriting Payable Charged To Additional Paidin Capital DeferredUnderwritingPayableChargedToAdditionalPaidinCapital	8704270	usd
CY2022	emld	Deferred Underwriting Payable Charged To Additional Paidin Capital DeferredUnderwritingPayableChargedToAdditionalPaidinCapital	1004270	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	2768000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1. ORGANIZATION AND BUSINESS OPERATIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FTAC Emerald Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on February 19, 2021, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company may pursue an initial Business Combination target in any business or industry.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2023, the Company had not commenced any operations. All activity for the period from February 19, 2021 (inception) through December 31, 2023 relates to the Company’s formation, the Public Offering (the “Public Offering” or “IPO”), and efforts in identifying a target to consummate an initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Public Offering placed in the Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s Sponsors are Emerald ESG Sponsor, LLC, a Delaware limited liability company, and Emerald ESG Advisors, LLC, a Delaware limited liability company (collectively, the “Sponsor”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registration statement for the Company’s Public Offering was declared effective on December 15, 2021 (the “Effective Date”). On December 20, 2021, the Company consummated its Public Offering of 22,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “public shares”) at $10.00 per Unit, which is discussed in Note 3, and the sale of 890,000 placement units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor, which is discussed in Note 4 (“Private Placement”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The underwriter of the Company’s IPO subsequently provided notice of its election to partially exercise its over-allotment option, and the closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on January 14, 2022. A total aggregate issuance by the Company of 2,869,342 Over-Allotment Option Units at a price of $10.00 per Over-Allotment Option Unit resulted in total gross proceeds of $28,693,420 to the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simultaneously with the issuance and sale of the Over-Allotment Option Units, the Company consummated the private sale of an additional 86,081 Private Placement Units (the “Additional Private Placement Units”) at a price of $10.00 per Additional Private Placement Unit to the Sponsor, generating gross proceeds of $860,810.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transaction costs related to the IPO and over-allotment amounted to $14,181,568, consisting of $4,973,868 of underwriting commissions, $8,704,270 in deferred underwriting fees, and $503,430 of other offering costs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company must complete one or more Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the Company’s signing a definitive agreement in connection with the initial Business Combination. However, the Company will only complete an initial Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the closing of the Public Offering, the partial exercise of the over-allotment option, and the sale of the Private Placement Units, a total of $251,180,354 ($10.10 per Unit) was placed in a Trust Account (“Trust Account”). The proceeds are invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except for any interest income released to the Company to pay franchise and income taxes and up to $100,000 of interest to pay dissolution expenses, none of the funds held in trust will be released from the Trust Account until the earlier of (i) the consummation of the initial Business Combination; (ii) the redemption of the public shares if the Company is unable to consummate a Business Combination by December 20, 2024 (the “Completion Window”); or (iii) the redemption of any public shares properly tendered in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to provide for the redemption of the public shares in connection with an initial Business Combination or to redeem 100% of the public shares if the Company has not consummated the initial Business Combination within the Completion Window, or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the public stockholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 19, 2023, the Company held a special meeting of its stockholders (the “Meeting”) at which the Company’s stockholders approved (A) an amendment (the “Charter Amendment”) to the Company’s Second Amended and Restated Certificate of Incorporation to extend the date by which the Company has to consummate its initial business combination from September 20, 2023 to January 19, 2024 (or such earlier date as determined by the Company’s Board of Directors); and (B) an amendment (the “Trust Amendment”) to the Company’s Investment Management Trust Agreement dated December 15, 2021, with Continental Stock Transfer & Trust Company, as trustee (the “Trust Agreement”), to allow the trustee to liquidate the Trust Account established in connection with the IPO at such time as may be determined by the Company as set forth in the Charter Amendment. In connection with the Meeting the holders of 9,239,192 shares of redeemable Class A common stock exercised their right to redeem their shares for cash at a redemption price of approximately $10.4762 per share, for an aggregate redemption amount of approximately $96,791,644. Following the redemptions, 15,630,150 shares of redeemable Class A common stock remained outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 19, 2024, the Company held a special meeting of its stockholders (the “January Meeting”) at which the Company’s stockholders approved (A) an amendment (the “January Charter Amendment”) to the Company’s Second Amended and Restated Certificate of Incorporation to extend the date by which the Company has to consummate its initial business combination from January 19, 2024 to December 20, 2024 (or such earlier date as determined by the Company’s Board of Directors); and (B) an amendment (the “January Trust Amendment”) to the Trust Agreement to allow the trustee to liquidate the Trust Account established in connection with the IPO at such time as may be determined by the Company as set forth in the January Charter Amendment. In connection with the January Meeting the holders of 10,872,266 shares of redeemable Class A common stock exercised their right to redeem their shares for cash at a redemption price of approximately $10.6224 per share, for an aggregate redemption amount of approximately $115,489,643. Following the redemptions, 4,757,884 shares of redeemable Class A common stock remain outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Liquidity and Capital Resources</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2023, the Company had $29,844 in cash and a working capital deficit of $3,087,967. Prior to the completion of the Company’s IPO, the Company’s liquidity needs had been satisfied through a capital contribution from the Sponsor of $25,000 and a loan to the Company of up to $300,000 by the Company’s Sponsor under an unsecured promissory note. The outstanding balance under the promissory note of $105,260 was repaid on December 27, 2021, and the promissory note was terminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes the initial Business Combination, the Company expects to repay such loaned amounts out of the proceeds of the Trust Account released to it. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts. At December 31, 2023 and 2022, $2,025,000 and $0 of Working Capital Loans were outstanding, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Going Concern</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 20, 2024 to consummate a Business Combination. It is uncertain whether the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management intends to consummate a Business Combination prior to December 20, 2024. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 20, 2024.</p>
CY2022Q1	emld	Units Issued During Period Shares New Issues UnitsIssuedDuringPeriodSharesNewIssues	2869342	shares
CY2023Q4	emld	Transaction Costs TransactionCosts	14181568	usd
CY2023	emld	Underwriting Commissions UnderwritingCommissions	4973868	usd
CY2023	emld	Deferred Underwriting Fees DeferredUnderwritingFees	8704270	usd
CY2023	emld	Other Offering Costs OtherOfferingCosts	503430	usd
CY2023	emld	Condition For Future Business Combination Use Of Proceeds Percentage ConditionForFutureBusinessCombinationUseOfProceedsPercentage	0.80	pure
CY2023	emld	Condition For Future Business Combination Threshold Percentage Ownership ConditionForFutureBusinessCombinationThresholdPercentageOwnership	0.50	pure
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	254251750	usd
CY2023	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P185D
CY2023	emld	Interest To Pay Dissolution Expenses InterestToPayDissolutionExpenses	100000	usd
CY2023Q4	emld	Funds Held In Trust FundsHeldInTrust	0	usd
CY2023Q4	emld	Percentage Of Public Shares Redeem PercentageOfPublicSharesRedeem	1	pure
CY2023Q3	emld	Redemption Price Of Per Share RedemptionPriceOfPerShare	10.4762
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	96791644	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	115489643	usd
CY2023Q4	us-gaap	Cash Cash	29844	usd
CY2023Q4	emld	Working Capital workingCapital	3087967	usd
CY2023Q4	us-gaap	Unsecured Debt UnsecuredDebt	300000	usd
CY2021Q4	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	105260	usd
CY2023	emld	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	2025000	usd
CY2022	emld	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	0	usd
CY2023	emld	Emerging Growth Company Status EmergingGrowthCompanyStatus	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Emerging Growth Company</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2023Q4	us-gaap	Cash Cash	29844	usd
CY2022Q4	us-gaap	Cash Cash	72753	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	165653149	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition.</p>
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022Q3	emld	Excise Tax Rate ExciseTaxRate	0.01	pure
CY2022Q3	emld	Fair Market Value Percentages FairMarketValuePercentages	0.01	pure
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	9239192	shares
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	967916	usd
CY2023	emld	Excise Tax Liability Percentage ExciseTaxLiabilityPercentage	0.01	pure
CY2022	emld	Gross Proceeds Including Overallotment GrossProceedsIncludingOverallotment	248693420	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	8264360	usd
CY2022	emld	Temporary Equity Issuance Cost TemporaryEquityIssuanceCost	13734146	usd
CY2022	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	27119341	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	253814255	usd
CY2023	us-gaap	Redemption Premium RedemptionPremium	96791644	usd
CY2023	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	8699271	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	165721882	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On June 2, 2021, the Sponsor purchased 7,992,750 shares of Class B common stock for an aggregate purchase price of $25,000, and on October 14, 2021, the Company effected a 1.1014-for-1.0 stock split, so that the Sponsor owned an aggregate of 8,803,333 shares of Class B common stock (the “Founder Shares”).
CY2023	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On November 12, 2021, the Company effected a 0.9955-for-1.0 stock split, so that the Sponsor owned an aggregate of 8,763,333 Founder Shares.
CY2023	emld	Founder Share Percentage FounderSharePercentage	1	pure
CY2023	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares (i) with respect to 25% of such shares, until consummation of the initial Business Combination, (ii) with respect to 25% of such shares, until the earlier of the second anniversary of the consummation of the initial Business Combination or the first date at which the closing price of the Class A common stock exceeds $12.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, (iii) with respect to 25% of such shares, until the earlier of the second anniversary of the consummation of the initial Business Combination or the first date at which the closing price of the Class A common stock exceeds $13.50 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, and (iv) with respect to 25% of such shares, until the earlier of the second anniversary of the consummation of the initial Business Combination or the first date at which the closing price of the Class A common stock exceeds $15.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination.
CY2023	emld	Working Capital Loans WorkingCapitalLoans	2025000	usd
CY2022	emld	Working Capital Loans WorkingCapitalLoans	0	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	30000	usd
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	360000	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	360000	usd
CY2023	us-gaap	Underwriting Expense Ratio UnderwritingExpenseRatio	0.02	pure
CY2023	emld	Deferred Underwriting Discount DeferredUnderwritingDiscount	0.035	pure
CY2023	emld	Gross Proceeds Of Public Offering GrossProceedsOfPublicOffering	8704270	usd
CY2022Q4	emld	Deferred Underwriters Discount DeferredUnderwritersDiscount	8704270	usd
CY2023	emld	Aggregate Percentage Underwritting Expenses AggregatePercentageUnderwrittingExpenses	0.003	pure
CY2023	emld	Advisory Fee Percentage advisoryFeePercentage	0.00525	pure
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1155000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1155000	usd
CY2023	emld	Aggregate Share AggregateShare	1610000	shares
CY2023	emld	Aggregate Fair Value Of Investor Shares AggregateFairValueOfInvestorShares	1610000	shares
CY2023	emld	Nonredemption Agreement Expense NonredemptionAgreementExpense	708400	usd
CY2023	emld	Non Redeeming Shareholders Par Value NonRedeemingShareholdersParValue	0.44
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023	emld	Description Of Exercise Price And Number Of Shares Of Common Stock DescriptionOfExercisePriceAndNumberOfSharesOfCommonStock	In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	165653149	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	254251750	usd
CY2023Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	1253839	usd
CY2022Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	350184	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1253839	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	350184	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1253839	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	350184	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2325087	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	726410	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-903665	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-329186	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	903665	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	329186	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2325087	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	726410	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	903665	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	329186	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1335	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.179	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.3435	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.389	pure
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1
CY2023	emld	Redemption Price Of Per Share RedemptionPriceOfPerShare	10.6224
CY2023Q4	emld	Reimbursement Receivable Non Current ReimbursementReceivableNonCurrent		usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent		usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2023Q4	emld	Deferred Underwriters Discount DeferredUnderwritersDiscount		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	emld	Nonredemption Agreement Expense NonredemptionAgreementExpense		usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2022	emld	Nonredemption Agreement Expense NonredemptionAgreementExpense		usd
CY2022	emld	Increase Decrease In Prepaid Income Taxes IncreaseDecreaseInPrepaidIncomeTaxes		usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2023	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments		usd
CY2022	emld	Proceedsfrom Cash Withdrawn From Trust Account In Connection With Redemption ProceedsfromCashWithdrawnFromTrustAccountInConnectionWithRedemption		usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022	emld	Excise Tax On Stock Redemption ExciseTaxOnStockRedemption		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards		usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001889123

Files In Submission

Name	View Source	Status
0001213900-24-025648-index-headers.html	Edgar Link	pending
0001213900-24-025648-index.html	Edgar Link	pending
0001213900-24-025648.txt	Edgar Link	pending
0001213900-24-025648-xbrl.zip	Edgar Link	pending
emld-20231231.xsd	Edgar Link	pending
f10k2023ex21-1_ftacemerald.htm	Edgar Link	pending
f10k2023ex31-1_ftacemerald.htm	Edgar Link	pending
f10k2023ex31-2_ftacemerald.htm	Edgar Link	pending
f10k2023ex32-1_ftacemerald.htm	Edgar Link	pending
f10k2023ex32-2_ftacemerald.htm	Edgar Link	pending
f10k2023ex97-1_ftacemerald.htm	Edgar Link	pending
f10k2023_ftacemer.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
emld-20231231_cal.xml	Edgar Link	unprocessable
emld-20231231_def.xml	Edgar Link	unprocessable
emld-20231231_lab.xml	Edgar Link	unprocessable
emld-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10k2023_ftacemer_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FLD
FTAC Emerald Acquisition Corp Stock $fld

2023 Q4 Form 10-K Financial Statement

#000121390024025648 Filed on March 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FLD FTAC Emerald Acquisition Corp Stock $fld

2023 Q4 Form 10-K Financial Statement

#000121390024025648 Filed on March 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FLD
FTAC Emerald Acquisition Corp Stock $fld